Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Calabresi

Showing results (31-40 of 469) with videos related to

Pageof 47
Sort By:
Neurology|July 6, 2012
Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis?Peter A Calabresi, Nicolaas I Bohnen
Cold Spring Harbor Perspectives in Biology|May 28, 2024
Multiple Sclerosis and Other Acquired Demyelinating Diseases of the Central Nervous SystemMichael D Kornberg, Peter A Calabresi
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 7, 2017
Ultra-high-field (7.0 Tesla and above) MRI is now necessary to make the next step forward in understanding MS pathophysiology - CommentaryPeter A Calabresi, Peter Cm van Zijl
Current Opinion in Pharmacology|March 7, 2022
Breaking the barriers to remyelination in multiple sclerosisMarjan Gharagozloo, Riley Bannon, Peter A Calabresi
Journal of Neuroimmunology|February 12, 2015
1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controlsPavan Bhargava, Anne Gocke, Peter A Calabresi
Annals of the New York Academy of Sciences|January 10, 2012
New and emerging disease modifying therapies for multiple sclerosisShiv Saidha, Christopher Eckstein, Peter A Calabresi
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 4, 2022
Response to-<i>Tracking the role of sphingolipids in MS: The dynamic nature of ceramide synthases</i>Pavan Bhargava, Norman Haughey, Peter A Calabresi
European Journal of Immunology|November 7, 2017
Dimethyl fumarate treatment alters NK cell function in multiple sclerosisMatthew D Smith, Peter A Calabresi, Pavan Bhargava
Annals of Neurology|April 23, 2022
Reply to "Interpretation of Longitudinal Changes of the Inner Nuclear Layer in MS"Elias S Sotirchos, Peter A Calabresi, Shiv Saidha
Expert Opinion on Investigational Drugs|October 17, 2008
FLT3 inhibitors for the treatment of autoimmune diseaseKatharine A Whartenby, Donald Small, Peter A Calabresi
Pageof 47

Showing results (31-40 of 469) with videos related to

Sort By:
Pageof 47
Neurology|July 6, 2012
Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis?Peter A Calabresi, Nicolaas I Bohnen
Cold Spring Harbor Perspectives in Biology|May 28, 2024
Multiple Sclerosis and Other Acquired Demyelinating Diseases of the Central Nervous SystemMichael D Kornberg, Peter A Calabresi
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 7, 2017
Ultra-high-field (7.0 Tesla and above) MRI is now necessary to make the next step forward in understanding MS pathophysiology - CommentaryPeter A Calabresi, Peter Cm van Zijl
Current Opinion in Pharmacology|March 7, 2022
Breaking the barriers to remyelination in multiple sclerosisMarjan Gharagozloo, Riley Bannon, Peter A Calabresi
Journal of Neuroimmunology|February 12, 2015
1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controlsPavan Bhargava, Anne Gocke, Peter A Calabresi
Annals of the New York Academy of Sciences|January 10, 2012
New and emerging disease modifying therapies for multiple sclerosisShiv Saidha, Christopher Eckstein, Peter A Calabresi
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 4, 2022
Response to-<i>Tracking the role of sphingolipids in MS: The dynamic nature of ceramide synthases</i>Pavan Bhargava, Norman Haughey, Peter A Calabresi
European Journal of Immunology|November 7, 2017
Dimethyl fumarate treatment alters NK cell function in multiple sclerosisMatthew D Smith, Peter A Calabresi, Pavan Bhargava
Annals of Neurology|April 23, 2022
Reply to "Interpretation of Longitudinal Changes of the Inner Nuclear Layer in MS"Elias S Sotirchos, Peter A Calabresi, Shiv Saidha
Expert Opinion on Investigational Drugs|October 17, 2008
FLT3 inhibitors for the treatment of autoimmune diseaseKatharine A Whartenby, Donald Small, Peter A Calabresi
Pageof 47